Postprints from IHPS
Parent: Institute for Health Policy Studies
eScholarship stats: History by Item for May through August, 2024
| Item | Title | Total requests | 2024-08 | 2024-07 | 2024-06 | 2024-05 |
|---|---|---|---|---|---|---|
| 458923p7 | Closing the Gap Between Research and Practice: An Overview of Systematic Reviews of Interventions to Promote Implementation of Research Findings by Health Care Professionals | 83 | 20 | 24 | 17 | 22 |
| 9w2773tz | Science in Regulatory Policy Making: Case Studies in the Development of Workplace Smoking Restrictions | 80 | 22 | 23 | 18 | 17 |
| 0qr8945r | Print Media Coverage of Research on Passive Smoking | 75 | 22 | 30 | 17 | 6 |
| 1p96m101 | How the tobacco industry responded to an influential study of the health effects of secondhand smoke | 68 | 24 | 21 | 15 | 8 |
| 2mj527c4 | Cigar Magazines: Using Tobacco to Sell A Lifestyle | 48 | 10 | 15 | 5 | 18 |
| 5tk8j863 | Scientific Quality of Original Research Articles on Environmental Tobacco Smoke | 47 | 22 | 19 | 3 | 3 |
| 4816j1zm | Evaluation of Probation Case Management (PCM) for Drug-Involved Women Offenders | 43 | 16 | 19 | 5 | 3 |
| 9b4848d9 | Tobacco Industry Response to a Risk Assessment of Environmental Tobacco Smoke | 34 | 15 | 12 | 4 | 3 |
| 3wx6m2hk | Making the Cigar News | 32 | 7 | 12 | 8 | 5 |
| 8g62x69s | Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review | 31 | 6 | 15 | 8 | 2 |
| 6dp961gw | Perspectives on the Drug Court Model Across Systems: A Process Evaluation | 29 | 16 | 11 | 2 | |
| 65k6g0xw | A Nicotine Delivery Device Without the Nicotine? Tobacco Industry Development of Low Nicotine Cigarettes | 25 | 8 | 9 | 5 | 3 |
| 9170d63n | The Limits of Competing Interest Disclosures | 23 | 4 | 10 | 7 | 2 |
| 05t2c9v4 | Does Centralized Intake Improve Drug Abuse Treatment Outcomes? | 22 | 6 | 7 | 3 | 6 |
| 2hp9d0q1 | Policy Makers’ Perspectives on Tobacco Control Advocates’ Roles in Regulation Development | 22 | 5 | 9 | 6 | 2 |
| 7v7675zg | Multi-Level Assessment Protocol (MAP) for Adoption in Multisite Clinical Trials | 22 | 6 | 11 | 2 | 3 |
| 8kt152b8 | Accepting Commercial Sponsorship | 21 | 7 | 9 | 5 | |
| 2mh5m74d | Evaluating Public Commentary and Scientific Evidence Submitted in the Development of A Risk Assessment | 14 | 2 | 7 | 3 | 2 |
Disclaimer: due to the evolving nature of the web traffic we receive and the methods we use to collate it, the data presented here should be considered approximate and subject to revision.